Regulation - North America, Mekinist

Filter

Current filters:

North AmericaMekinist

Popular Filters

GlaxoSmithKline files sNDAs for combination melanoma drugs

09-07-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said today (July 9) that it has submitted supplemental New…

BiotechnologyGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

FDA approves two GSK melanoma drugs and bioMerieux companion diagnostic

30-05-2013

The US Food and Drug Administration yesterday (May 29) approved two new oral drugs from UK pharma giant…

BioMerieuxdabrafenibGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlartrametinib

Back to top